RESPONSE BY STAGE IN CD30-POSITIVE (CD30+) CUTANEOUS T CELL...

Hematological Oncology 2017 / 06 Vol. 35

RESPONSE BY STAGE IN CD30-POSITIVE (CD30+) CUTANEOUS T CELL LYMPHOMA (CTCL) PATIENTS RECEIVING BRENTUXIMAB VEDOTIN (BV) VS PHYSICIAN'S CHOICE (PC) IN THE PHASE 3 ALCANZA STUDY

Horwitz, S., Whittaker, S., Duvic, M., Dummer, R., Kim, Y.H., Scarisbrick, J., Quaglino, P., Zinzani, P., Wolter, P., Eradat, H., Sanches, J., Ortiz-Romero, P., Akilov, O., Trotman, J., Taylor, K., Da
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
35
Language:
english
Journal:
Hematological Oncology
DOI:
10.1002/hon.2438_109
Date:
June, 2017
File:
PDF, 106 KB
english, 2017
Conversion to is in progress
Conversion to is failed